Suchergebnisse - "Lefèvre, Gilbert"

PubPharm (16)

1

Effects of Renal Impairment on Steady-State Plasma Concentrations of Rivastigmine : A Population Pharmacokinetic Analysis of Capsule and Patch Formulations in Patients with Alzheimer's Disease

enthalten in: Drugs & aging | 2016

von Lefèvre, G. | Callegari, F. | Gsteiger, S. | +1

2

Open-label, single-dose, parallel-group study in healthy volunteers to determine the drug-drug interaction potential between KAE609 (cipargamin) and piperaquine

enthalten in: Antimicrobial agents and chemotherapy | 2015

von Stein, D. | Jain, J. | Kangas, M. | +4

3

A first-in-human randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study of novel antimalarial Spiroindolone KAE609 (Cipargamin) to assess its safety, tolerability, and pharmacokinetics in healthy adult volunteers

enthalten in: Antimicrobial agents and chemotherapy | 2014

von Leong, F. | Li, R. | Jain, J. | +4

4

Evaluation of two novel tablet formulations of artemether-lumefantrine (Coartem) for bioequivalence in a randomized, open-label, two-period study

enthalten in: Malaria journal | 2013

von Lefèvre, G. | Bhad, P. | Jain, J. | +4

5

Randomized, prospective, three-arm study to confirm the auditory safety and efficacy of artemether-lumefantrine in Colombian patients with uncomplicated Plasmodium falciparum malaria

enthalten in: The American journal of tropical medicine and hygiene | 2012

von Carrasquilla, G. | Barón, C. | Monsell, E. | +5

6

Similar efficacy and safety of artemether-lumefantrine (Coartem®) in African infants and children with uncomplicated falciparum malaria across different body weight ranges

enthalten in: Malaria journal | 2011

von Bassat, Q. | González, R. | Machevo, S. | +13

7

Pharmacokinetic and pharmacodynamic characteristics of a new pediatric formulation of artemether-lumefantrine in African children with uncomplicated Plasmodium falciparum malaria

enthalten in: Antimicrobial agents and chemotherapy | 2011

von Djimdé, A. | Tekete, M. | Abdulla, S. | +45

ErratumIn: Antimicrob Agents Chemother. 2012 Oct;56(10):5429 Klouwenberg, P K [corrected to Klein Klouwenberg, P]

8

Early clinical development of artemether-lumefantrine dispersible tablet : palatability of three flavours and bioavailability in healthy subjects

enthalten in: Malaria journal | 2010

von Abdulla, S. | Amuri, B. | Kabanywanyi, A. | +9

9

The effect of food consumption on lumefantrine bioavailability in African children receiving artemether-lumefantrine crushed or dispersible tablets (Coartem) for acute uncomplicated Plasmodium falciparum malaria

enthalten in: Tropical medicine & international health : TM & IH | 2010

von Borrmann, S. | Sallas, W. | Machevo, S. | +12

10

Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria : a randomised, single-blind, multicentre trial

enthalten in: Lancet (London, England) | 2008

von Abdulla, S. | Sagara, I. | Borrmann, S. | +19

CommentIn: Lancet. 2008 Nov 22;372(9652):1786-7. - PMID 18926568